Routt E. Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing. J of Skin [Internet]. 2019Mar.11 [cited 2024Sep.20];3(2):150-1. Available from: https://dermsquared.com/skin/article/view/587